Articolo | 03.11.2026
Blog e news
topic :
category :
:
Webinar | 03.11.2026
Dalla MASLD alla MASH: come identificare l’infiammazione epatica e stratificare il rischio
Articolo | 03.11.2026
New Baveno VIII Guidelines Reinforce FibroScan® and VCTE® for Portal Hypertension Assessment
Webinar | 03.11.2026
Baveno VIII in pratica: come i test non invasivi stanno trasformando la gestione dell’ipertensione portale
Comunicato stampa | 03.11.2026
Echosens Appoints Romain Baujard as Group Chief Executive Officer
White Paper | 17.04.2026
New White Paper – Vibration-Controlled Transient Elastography Explained
Webinar | 03.11.2026
Colangite Biliare Primitiva (CBP): focus sulla stratificazione del rischio per un corretto management clinico
Articolo | 03.11.2026
Statement on the acceptance by the FDA of Echosens’ Letter of Intent for Drug Development Tool (DDT)
Articolo | 03.11.2026
A New Era for Liver Care: Prof. Dr. Jörn Schattenberg on the EC Approval of Rezdiffra™ for MASH
Comunicato stampa | 03.11.2026
Echosens and Novo Nordisk Advance Partnership to Increase Awareness and Early Diagnosis of MASH
Comunicato stampa | 03.11.2026
Echosens and United Digestive Partner to Expand Access to Non-Invasive Liver Diagnostics
Comunicato stampa | 03.11.2026
Echosens and Boehringer Ingelheim Expand Long-Standing Collaboration to Accelerate Progress in MASH Diagnosis and Care
Articolo | 03.11.2026
A call for doubling the diagnostic rate of at-risk MASH
Congress | 24.04.2026
Echosens is at EASL
Webinar | 03.11.2026